Researchers may have discovered a new target when treating an especially difficult breast cancer.
According to a reporting issued in the Journal of Clinical Investigation, a protein, named TGF-8, was seen by researchers as being visible in the cells of triple negative cancers--even after those cells underwent chemotherapy.
Researchers go on to say that the protein, in mouse studies, diverted cells down a path to becoming cancerous--or helped in the return of cancer cells after treatment.
Even more interesting, when the TGF-8 was lowered in mice, it stopped tumors from recurring.
Although more studies in humans are needed, it could help create a new and better cancer treatment.
Copyright 2013 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
One person will win a three-year lease on a 2013 Honda Civic Lx Sedan automatic.
Click to see the latest mugshots, plus this week's wanted fugitives.
This feature packed upgrade brings you faster performance, easier navigation, and stunning improvements to photos, video and readability.
Latest Health Headlines
Nearly three million Americans are infected with hepatitis "C" which can trigger potentially fatal liver diseases.